PetMed Express Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report was filed by PetMed Express Inc. on September 12, 2025, covering events that occurred on September 8, 2025. The filing addresses executive compensation and equity awards under Item 5.02.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel compensation arrangements.
Material Changes and Executive Actions
- Interim CEO Compensation: The Board approved an initial annual base salary of $550,000 for Leslie C.G. Campbell, who serves as Interim Chief Executive Officer and President. This salary covers the period beginning August 11, 2025, until a formal employment agreement is executed. Ms. Campbell is also entitled to standard senior executive health and benefits.
- Equity Award: The Board approved a restricted stock award of 10,000 shares to Douglas Krulik, Chief Accounting Officer and Interim Principal Financial Officer. The award was granted on September 9, 2025, under the 2024 Omnibus Incentive Plan.
- Vesting Terms: Mr. Krulik's award vests in full 6 months after the grant date, contingent on continued employment, or earlier if terminated without "cause."
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the standard vesting conditions of the equity award.
Key Facts for Investor Verification
- Confirmation of the formal employment agreement timeline for Interim CEO Leslie C.G. Campbell.
- Market value of the 10,000 restricted shares granted to Douglas Krulik on September 9, 2025.
- Details regarding the transition from interim to permanent leadership roles.